Ipilimumab HY-P9901 from MedChemExpress

Product Specs
ItemIpilimumab
CompanyMedChemExpress
Price $550.00Supplier Page View Company Product Page
Catalog NumberHY-P9901
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.88%
Research AreaCancer
TypeChemical
Molecular Weight145313.36
Quantity1 mg
Molecule NameIpilimumab

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

(1) Combined Nivolumab and Ipilimumab Therapy Promotes Immune-Mediated Cardiomyocyte Apoptosis Through TLR4-Myd88-NF-Κb-Driven Activation of the NLRP3 InflammasomeHum MutatApril 23, 2026Mengjiao Gao, Xinya Liu, Li Wu, Yun Jiang, Jian Yu, Yuanming Zhang(anti‐CTLA‐4) CTLA‐4 inhibitor was purchased from MCE (United States) Biotechnology Company, Product Number HY‐P9901; the si‐TLR4 inhibitor was purchased from Guangzhou Ruibo; and the si‐NLRP3 inhibitor was purchased

(2) CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergyFrontiers in OncologyNovember 19, 2025Peifang Chen, Jianrong Pan, Ling Chen, Xiushan Fengprotocols. 2.2 Reagents and antibodies Immune checkpoint inhibitors Nivolumab (HY-P9903, MCE) and Ipilimumab (HY-P9901, MCE); apoptosis and cell cycle detection kits Annexin V-FITC/PI (CA1020, Solarbio) and DNA Content

Ipilimumab from MedChemExpress